| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.077 | 0.2 |